Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2013-04-17 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
2013年第一季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2013 First Quarter Report" of 嘉事堂药业股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data for the first quarter of 2013, including income, net profit, cash flow, shareholder information, and explanations of financial changes. The presence of actual financial statements and substantive financial data confirms it is a comprehensive interim report rather than a brief announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2013
2013-04-17 Chinese
第四届董事会第五次会议决议的公告
Regulatory Filings Classification · 90% confidence The document is an announcement of the resolutions passed at the fifth meeting of the fourth board of directors of 嘉事堂药业股份有限公司. It specifically mentions the approval of the '2013 first quarter report' by the board. The document is short (537 characters) and serves as a formal announcement of the board meeting decisions rather than the report itself. It does not contain the actual financial data or detailed report content but confirms the approval of the quarterly report. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a formal announcement related to corporate governance and report approval, not the report itself.
2013-04-17 Chinese
关于股东减持股份的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a notification about a shareholder reducing their shareholding in the company 嘉事堂药业股份有限公司. It details the number of shares sold, the method of sale, dates, and the percentage of total shares held before and after the sale. It also references compliance with relevant regulations and mentions a related '简式权益变动报告书' (simplified equity change report) filed elsewhere. This type of document is a notification of a change in major shareholding levels, which fits the category of Major Shareholding Notification (MRQ). The document length is short and focused solely on shareholding changes, not a full financial report or other filings.
2013-04-01 Chinese
简式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the change in shareholding of a significant shareholder (新产业投资股份有限公司) in 嘉事堂药业股份有限公司, including the number of shares held before and after the change, the method of change (large block trade on Shenzhen Stock Exchange), and other related disclosures. It references compliance with Chinese securities laws and regulations regarding disclosure of shareholding changes. The document is about a change in major shareholding and does not contain financial statements, earnings data, or management discussion. It is not an announcement of a report publication but a substantive report on shareholding changes. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length is 4283 characters, which is consistent with a detailed shareholding change report rather than a brief announcement or a full annual/interim report.
2013-04-01 Chinese
独立董事2012年度述职报告（马永义）
Board/Management Information Classification · 95% confidence The document is an independent director's annual performance report for the year 2012. It details the director's attendance at meetings, opinions on company matters, supervision activities, and communication with management regarding the annual report preparation. The content focuses on governance and oversight activities rather than presenting financial statements or audit results. It is not a full annual report (10-K), audit report (AR), or management report (MDA). Instead, it is a report related to board/management information, specifically the independent director's duties and opinions. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is 2460 characters, which is consistent with a detailed director report but not a full financial report.
2013-03-27 Chinese
独立董事2012年度述职报告（武文生）
Board/Management Information Classification · 95% confidence The document is a detailed annual report by an independent director for the year 2012, describing the director's duties, attendance at meetings, opinions on company matters, and involvement in the annual report preparation. It includes specific references to the 2012 annual report and audit work, but it is not the annual report itself. Instead, it is a formal report on the independent director's activities and opinions related to governance and oversight for the year. This fits best under Board/Management Information (MANG), as it relates to the independent director's report on their role and governance activities rather than a full annual report or audit report. The document length is 2462 characters, which is relatively short and focused on director duties and opinions, not full financial statements or audit results. Therefore, the classification is MANG with high confidence.
2013-03-27 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.